Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1976 1
1990 1
1991 3
1994 1
1995 3
1996 4
1997 2
1998 4
1999 8
2000 3
2001 3
2002 6
2003 8
2004 6
2005 5
2006 13
2007 10
2008 10
2009 14
2010 14
2011 10
2012 6
2013 10
2014 8
2015 10
2016 28
2017 20
2018 16
2019 10
2020 13
2021 9
2022 11
2023 6
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

241 results

Results by year

Filters applied: . Clear all
Page 1
Proteomic and phosphoproteomic landscapes of acute myeloid leukemia.
Kramer MH, Zhang Q, Sprung R, Day RB, Erdmann-Gilmore P, Li Y, Xu Z, Helton NM, George DR, Mi Y, Westervelt P, Payton JE, Ramakrishnan SM, Miller CA, Link DC, DiPersio JF, Walter MJ, Townsend RR, Ley TJ. Kramer MH, et al. Blood. 2022 Sep 29;140(13):1533-1548. doi: 10.1182/blood.2022016033. Blood. 2022. PMID: 35895896 Free PMC article.
Prehospital antibiotics in the ambulance for sepsis: a multicentre, open label, randomised trial.
Alam N, Oskam E, Stassen PM, Exter PV, van de Ven PM, Haak HR, Holleman F, Zanten AV, Leeuwen-Nguyen HV, Bon V, Duineveld BAM, Nannan Panday RS, Kramer MHH, Nanayakkara PWB; PHANTASi Trial Investigators and the ORCA (Onderzoeks Consortium Acute Geneeskunde) Research Consortium the Netherlands. Alam N, et al. Among authors: kramer mhh. Lancet Respir Med. 2018 Jan;6(1):40-50. doi: 10.1016/S2213-2600(17)30469-1. Epub 2017 Nov 28. Lancet Respir Med. 2018. PMID: 29196046 Clinical Trial.
Landelijke diabetesregistratie DPARD: vijf jaar succesvol op weg.
Verheugt CL, de Vries SAG, Bak JCG, Serné EH, Kramer MHH. Verheugt CL, et al. Among authors: kramer mhh. Ned Tijdschr Diabetol. 2023;21(1):13-15. doi: 10.1007/s12467-023-1212-9. Epub 2023 Mar 8. Ned Tijdschr Diabetol. 2023. PMID: 36909670 Free PMC article. Dutch. No abstract available.
Dabigatran versus warfarin in the treatment of acute venous thromboembolism.
Schulman S, Kearon C, Kakkar AK, Mismetti P, Schellong S, Eriksson H, Baanstra D, Schnee J, Goldhaber SZ; RE-COVER Study Group. Schulman S, et al. N Engl J Med. 2009 Dec 10;361(24):2342-52. doi: 10.1056/NEJMoa0906598. N Engl J Med. 2009. PMID: 19966341 Free article. Clinical Trial.
The renal hemodynamic effects of the SGLT2 inhibitor dapagliflozin are caused by post-glomerular vasodilatation rather than pre-glomerular vasoconstriction in metformin-treated patients with type 2 diabetes in the randomized, double-blind RED trial.
van Bommel EJM, Muskiet MHA, van Baar MJB, Tonneijck L, Smits MM, Emanuel AL, Bozovic A, Danser AHJ, Geurts F, Hoorn EJ, Touw DJ, Larsen EL, Poulsen HE, Kramer MHH, Nieuwdorp M, Joles JA, van Raalte DH. van Bommel EJM, et al. Among authors: kramer mhh. Kidney Int. 2020 Jan;97(1):202-212. doi: 10.1016/j.kint.2019.09.013. Epub 2019 Oct 10. Kidney Int. 2020. PMID: 31791665 Free article. Clinical Trial.
Effectiveness of managing suspected pulmonary embolism using an algorithm combining clinical probability, D-dimer testing, and computed tomography.
van Belle A, Büller HR, Huisman MV, Huisman PM, Kaasjager K, Kamphuisen PW, Kramer MH, Kruip MJ, Kwakkel-van Erp JM, Leebeek FW, Nijkeuter M, Prins MH, Sohne M, Tick LW; Christopher Study Investigators. van Belle A, et al. Among authors: kramer mh. JAMA. 2006 Jan 11;295(2):172-9. doi: 10.1001/jama.295.2.172. JAMA. 2006. PMID: 16403929
Short versus extended treatment with a carbapenem in patients with high-risk fever of unknown origin during neutropenia: a non-inferiority, open-label, multicentre, randomised trial.
de Jonge NA, Sikkens JJ, Zweegman S, Beeker A, Ypma P, Herbers AH, Vasmel W, de Kreuk A, Coenen JLLM, Lissenberg-Witte B, Kramer MHH, van Agtmael MA, Janssen JJWM. de Jonge NA, et al. Among authors: kramer mhh. Lancet Haematol. 2022 Aug;9(8):e563-e572. doi: 10.1016/S2352-3026(22)00145-4. Epub 2022 Jun 9. Lancet Haematol. 2022. PMID: 35691326 Clinical Trial.
Imatinib-induced pseudoporphyria.
Timmer-de Mik L, Kardaun SH, Kramer MH, Hayes DP, Bousema MT. Timmer-de Mik L, et al. Among authors: kramer mh. Clin Exp Dermatol. 2009 Aug;34(6):705-7. doi: 10.1111/j.1365-2230.2008.02985.x. Epub 2008 Dec 9. Clin Exp Dermatol. 2009. PMID: 19077095
241 results